Have you or your loved ones been diagnosed with copd (chronic obstructive pulmonary disease)?

You may be eligible to participate in a copd (chronic obstructive pulmonary disease) clinical trial.

Have you or your loved ones been diagnosed with copd (chronic obstructive pulmonary disease)? You may be eligible to participate in a copd (chronic obstructive pulmonary disease) clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trial
NCT03197818 | Phase 3 | Interventional

Have you or your loved ones been diagnosed with copd (chronic obstructive pulmonary disease)?

You may be eligible to participate in a copd (chronic obstructive pulmonary disease) clinical trial.

Have you or your loved ones been diagnosed with copd (chronic obstructive pulmonary disease)? You may be eligible to participate in a copd (chronic obstructive pulmonary disease) clinical trial.

Completed

Male & Female

40 Years +

This study has recruited 990 Participants

The purpose of this study is to demonstrate the superiority of CHF 5993 pMDI (fixed combination of extrafine beclometasone dipropionate plus formoterol fumarate plus glycopyrronium bromide) over Symbicort® Turbuhaler® in terms of pulmonary function, as well as to assess its safety.